news & analysis
Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery
September 10, 2020, by Leah Rosenbaum, Forbes Staff
The Utah-based biotech company’s agreement with Bayer is potentially worth over $1 billion.
Read more on Forbes - AI
news & analysis
Telltale Signs: AI Researchers Trace Cancer Risk Factors Using Tumor DNA
September 8, 2020, by Isha Salian
Life choices can change a person’s DNA — literally. Gene changes that occur ...
Read more on NVIDIA
news & analysis
Gates Foundation awards $800K grant to A-Alpha Bio for COVID-19 treatment research
July 9, 2020, by Lisa Stiffler
A-Alpha Bio was founded by University of Washington PhD graduates David Younger (standing) ...
Read more on GeekWire
news & analysis
Mass General’s Martinos Center Adopts AI for COVID, Radiology Research
August 10, 2020, by Rory Kelleher
Academic medical centers worldwide are building new AI tools to battle COVID-19 — ...
Read more on NVIDIA